These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17293538)

  • 1. A truncation in the RYR1 gene associated with central core lesions in skeletal muscle fibres.
    Rossi D; De Smet P; Lyfenko A; Galli L; Lorenzini S; Franci D; Petrioli F; Orrico A; Angelini C; Tegazzin V; Dirksen R; Sorrentino V
    J Med Genet; 2007 Feb; 44(2):e67. PubMed ID: 17293538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
    Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease.
    Vukcevic M; Broman M; Islander G; Bodelsson M; Ranklev-Twetman E; Müller CR; Treves S
    Anesth Analg; 2010 Jul; 111(1):185-90. PubMed ID: 20142353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype.
    Sambuughin N; McWilliams S; de Bantel A; Sivakumar K; Nelson TE
    Am J Hum Genet; 2001 Jul; 69(1):204-8. PubMed ID: 11389482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of ryanodine receptor type 1 p.R2508C mutation in exon 47.
    Migita T; Mukaida K; Hamada H; Yasuda T; Haraki T; Nishino I; Murakami N; Kawamoto M
    J Anesth; 2009; 23(3):341-6. PubMed ID: 19685112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation.
    Gomez AC; Holford TW; Yamaguchi N
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C749-C757. PubMed ID: 27558158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and functional analysis of the RYR1 mutation p.Thr84Met revealed a susceptibility to malignant hyperthermia.
    Kondo T; Yasuda T; Mukaida K; Otsuki S; Kanzaki R; Miyoshi H; Hamada H; Nishino I; Kawamoto M
    J Anesth; 2018 Apr; 32(2):174-181. PubMed ID: 29344738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
    Loy RE; Orynbayev M; Xu L; Andronache Z; Apostol S; Zvaritch E; MacLennan DH; Meissner G; Melzer W; Dirksen RT
    J Gen Physiol; 2011 Jan; 137(1):43-57. PubMed ID: 21149547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model.
    Wehner M; Rueffert H; Koenig F; Olthoff D
    Neuromuscul Disord; 2004 Jul; 14(7):429-37. PubMed ID: 15210166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.
    Yang T; Ta TA; Pessah IN; Allen PD
    J Biol Chem; 2003 Jul; 278(28):25722-30. PubMed ID: 12732639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in a malignant hyperthermia family by sequencing of a leukocyte transcript.
    Loke JC; Kraev N; Sharma P; Du G; Patel L; Kraev A; MacLennan DH
    Anesthesiology; 2003 Aug; 99(2):297-302. PubMed ID: 12883402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice.
    Feng W; Barrientos GC; Cherednichenko G; Yang T; Padilla IT; Truong K; Allen PD; Lopez JR; Pessah IN
    Mol Pharmacol; 2011 Mar; 79(3):420-31. PubMed ID: 21156754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.
    Yang T; Riehl J; Esteve E; Matthaei KI; Goth S; Allen PD; Pessah IN; Lopez JR
    Anesthesiology; 2006 Dec; 105(6):1164-75. PubMed ID: 17122579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage.
    Yuen B; Boncompagni S; Feng W; Yang T; Lopez JR; Matthaei KI; Goth SR; Protasi F; Franzini-Armstrong C; Allen PD; Pessah IN
    FASEB J; 2012 Mar; 26(3):1311-22. PubMed ID: 22131268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).
    Du GG; Oyamada H; Khanna VK; MacLennan DH
    Biochem J; 2001 Nov; 360(Pt 1):97-105. PubMed ID: 11695996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harboring malignant hyperthermia and central core disease mutations.
    Brini M; Manni S; Pierobon N; Du GG; Sharma P; MacLennan DH; Carafoli E
    J Biol Chem; 2005 Apr; 280(15):15380-9. PubMed ID: 15689621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of the RYR1 mutation p.Arg4737Trp associated with susceptibility to malignant hyperthermia.
    Johannsen S; Treves S; Müller CR; Mögele S; Schneiderbanger D; Roewer N; Schuster F
    Neuromuscul Disord; 2016 Jan; 26(1):21-5. PubMed ID: 26631338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.
    Samões R; Oliveira J; Taipa R; Coelho T; Cardoso M; Gonçalves A; Santos R; Melo Pires M; Santos M
    J Neuromuscul Dis; 2017; 4(1):67-76. PubMed ID: 28269792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels.
    Tong J; McCarthy TV; MacLennan DH
    J Biol Chem; 1999 Jan; 274(2):693-702. PubMed ID: 9873004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.